Fu‐sheng Wang
#135,651
Most Influential Person Now
Fu‐sheng Wang's AcademicInfluence.com Rankings
Fu‐sheng Wangphilosophy Degrees
Philosophy
#6829
World Rank
#9935
Historical Rank
Logic
#3934
World Rank
#5167
Historical Rank

Fu‐sheng Wangbiology Degrees
Biology
#9276
World Rank
#12462
Historical Rank
Pathology
#121
World Rank
#237
Historical Rank

Download Badge
Philosophy Biology
Fu‐sheng Wang's Degrees
- Bachelors Biology University of California, Berkeley
- Doctorate Medicine Stanford University
Similar Degrees You Can Earn
Why Is Fu‐sheng Wang Influential?
(Suggest an Edit or Addition)Fu‐sheng Wang's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome (2020) (6784)
- Liver injury in COVID-19: management and challenges (2020) (1460)
- A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2 (2020) (1085)
- The global burden of liver disease: The major impact of China (2014) (944)
- Human autoimmune diseases: a comprehensive update (2015) (510)
- A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity (2020) (506)
- Circulating and Liver Resident CD4+CD25+ Regulatory T Cells Actively Influence the Antiviral Immune Response and Disease Progression in Patients with Hepatitis B1 (2006) (449)
- Single-cell landscape of immunological responses in patients with COVID-19 (2020) (399)
- PD‐1 and PD‐L1 upregulation promotes CD8+ T‐cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients (2011) (388)
- Interleukin‐17–producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B (2010) (373)
- PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors. (2007) (315)
- Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients (2012) (308)
- Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis (2020) (291)
- Immunological and inflammatory profiles in mild and severe cases of COVID-19 (2020) (276)
- Human Mesenchymal Stem Cell Transfusion Is Safe and Improves Liver Function in Acute‐on‐Chronic Liver Failure Patients (2012) (276)
- Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. (2008) (252)
- In vivo consequences of liver‐specific interleukin‐22 expression in mice: Implications for human liver disease progression (2011) (206)
- What to do next to control the 2019-nCoV epidemic? (2020) (202)
- Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial (2020) (199)
- The role of neutrophils in the development of liver diseases (2014) (182)
- Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience (2020) (171)
- Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages (2014) (165)
- Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19) (2020) (165)
- Pathological functions of interleukin‐22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment (2014) (154)
- Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients (2011) (153)
- Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. (2008) (151)
- A pilot study of umbilical cord‐derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis (2013) (148)
- Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma (2013) (142)
- Liver fibrosis: mechanisms of immune-mediated liver injury (2011) (140)
- B7-H1 Up-Regulation on Myeloid Dendritic Cells Significantly Suppresses T Cell Immune Function in Patients with Chronic Hepatitis B1 (2007) (135)
- Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial (2021) (133)
- Hyper-Activated Pro-Inflammatory CD16+ Monocytes Correlate with the Severity of Liver Injury and Fibrosis in Patients with Chronic Hepatitis B (2011) (110)
- Stem cell therapies for liver failure and cirrhosis. (2013) (94)
- Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure. (2008) (94)
- Decreased Ratio of Treg Cells to Th17 Cells Correlates with HBV DNA Suppression in Chronic Hepatitis B Patients Undergoing Entecavir Treatment (2010) (91)
- Imbalanced Intrahepatic Cytokine Expression of Interferon-γ, Tumor Necrosis Factor-α, and Interleukin-10 in Patients With Acute-on-Chronic Liver Failure Associated With Hepatitis B Virus Infection (2009) (91)
- CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis (2015) (91)
- The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV‐1‐infected typical progressors, but not in long‐term non‐progressors (2009) (83)
- Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients (2020) (82)
- Immune responses during COVID-19 infection (2020) (81)
- SARS-associated coronavirus quasispecies in individual patients. (2004) (75)
- A Pilot Study of Mesenchymal Stem Cell Therapy for Acute Liver Allograft Rejection (2017) (74)
- A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19 (2021) (73)
- Comparative study on virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients (2020) (72)
- Impaired Function of CD4+ T Follicular Helper (Tfh) Cells Associated with Hepatocellular Carcinoma Progression (2015) (69)
- Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients (2015) (68)
- Differential Restoration of Myeloid and Plasmacytoid Dendritic Cells in HIV-1-Infected Children after Treatment with Highly Active Antiretroviral Therapy1 (2006) (67)
- HIV-1 subtype B’ dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China (2003) (67)
- Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus (2009) (65)
- Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patients (2013) (65)
- Plasmacytoid dendritic cells promote HIV-1-induced group 3 innate lymphoid cell depletion. (2015) (64)
- Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection (2012) (64)
- B7‐H1 up‐regulation impairs myeloid DC and correlates with disease progression in chronic HIV‐1 infection (2008) (62)
- Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients (2015) (62)
- Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis. (2018) (59)
- Current advances in the elimination of hepatitis B in China by 2030 (2017) (59)
- Plasmacytoid dendritic cells act as the most competent cell type in linking antiviral innate and adaptive immune responses. (2005) (56)
- Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients. (2009) (50)
- Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients (2017) (49)
- Natural Killer Cells Are Characterized by the Concomitantly Increased Interferon-γ and Cytotoxicity in Acute Resolved Hepatitis B Patients (2012) (48)
- Myeloid-Derived Suppressor Cells Are Associated with Viral Persistence and Downregulation of TCR ζ Chain Expression on CD8+ T Cells in Chronic Hepatitis C Patients (2014) (48)
- Neutrophils in liver diseases: pathogenesis and therapeutic targets (2020) (48)
- Polymorphisms of the PRNP gene in Chinese populations and the identification of a novel insertion mutation (2004) (47)
- Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice (2017) (43)
- Breach of Tolerance: Primary Biliary Cirrhosis (2014) (43)
- Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants (2020) (42)
- High circulating CD39(+) regulatory T cells predict poor survival for sepsis patients. (2015) (41)
- Compartmentalization and its implication for peripheral immunologically‐competent cells to the liver in patients with HBV‐related acute‐on‐chronic liver failure (2009) (41)
- CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection (2009) (40)
- Guidelines for the Diagnosis and Management of Herb-Induced Liver Injury (2018) (40)
- Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy — Achieving global consensus and visibility for cellular host-directed therapies (2020) (38)
- Improved survival ratios correlate with myeloid dendritic cell restoration in acute-on-chronic liver failure patients receiving methylprednisolone therapy (2012) (35)
- High levels of circulating GM-CSF+CD4+ T cells are predictive of poor outcomes in sepsis patients: a prospective cohort study (2018) (35)
- NLRP3 inflammasome induces CD4+ T cell loss in chronically HIV-1-infected patients. (2021) (35)
- COVID-19 in people with HIV (2020) (32)
- Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors. (2015) (31)
- Cutting Edge: Programmed Death-1 Up-Regulation Is Involved in the Attrition of Cytomegalovirus-Specific CD8+ T Cells in Acute Self-Limited Hepatitis B Virus Infection1 (2008) (31)
- B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation. (2011) (31)
- Immunometabolism: new insights and lessons from antigen-directed cellular immune responses (2020) (30)
- Mesenchymal stem cell therapy for severe COVID-19 (2021) (30)
- Sofosbuvir and ABT-450: terminator of hepatitis C virus? (2013) (30)
- Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes. (2016) (30)
- The Ratio of Circulating Regulatory T Cells (Tregs)/Th17 Cells Is Associated with Acute Allograft Rejection in Liver Transplantation (2014) (30)
- Increased circulating level of interleukin-6 and CD8+ T cell exhaustion are associated with progression of COVID-19 (2020) (29)
- Complement 5a receptor-mediated neutrophil dysfunction is associated with a poor outcome in sepsis (2015) (29)
- Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia–Pacific region and Russia: Final results from the randomized C‐CORAL study (2018) (28)
- Skewed ratios between CD3(+) T cells and monocytes are associated with poor prognosis in patients with HBV-related acute-on-chronic liver failure. (2010) (28)
- Decreased Vδ2 γδ T cells associated with liver damage by regulation of Th17 response in patients with chronic hepatitis B. (2013) (28)
- Liver: How can acute-on-chronic liver failure be accurately identified? (2013) (27)
- Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challenges (2019) (27)
- Progressive CD127 down‐regulation correlates with increased apoptosis of CD8 T cells during chronic HIV‐1 infection (2009) (27)
- Low expression of CXCR1/2 on neutrophils predicts poor survival in patients with hepatitis B virus-related acute-on-chronic liver failure (2016) (24)
- The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope. (2007) (24)
- Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome (2005) (23)
- Preferential loss of Th17 cells is associated with CD4 T cell activation in patients with 2009 pandemic H1N1 swine-origin influenza A infection (2010) (23)
- Genetic Variation of SARS Coronavirus in Beijing Hospital (2004) (22)
- Virtual memory CD8+ T cells restrain the viral reservoir in HIV-1-infected patients with antiretroviral therapy through derepressing KIR-mediated inhibition (2020) (22)
- Predictors of coronavirus disease 2019 severity: A retrospective study of 64 cases. (2020) (21)
- Tripterygium wilfordii Hook F extract in cART-treated HIV patients with poor immune response: a pilot study to assess its immunomodulatory effects and safety (2015) (20)
- Regulation of T cell function by microRNA-720 (2015) (20)
- Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: Progress and challenges (2007) (20)
- Randomized double-blinded and controlled clinical trial on treatment of HIV/AIDS by Zhongyan-4. (2006) (19)
- Complement 5a stimulates hepatic stellate cells in vitro, and is increased in the plasma of patients with chronic hepatitis B (2013) (19)
- Dichotomous Roles of Programmed Cell Death 1 on HIV-Specific CXCR5+ and CXCR5− CD8+ T Cells during Chronic HIV Infection (2017) (18)
- HCV-specific interleukin-21+CD4+ T cells responses associated with viral control through the modulation of HCV-specific CD8+ T cells function in chronic hepatitis C patients (2013) (18)
- Response to interferon-α treatment correlates with recovery of blood plasmacytoid dendritic cells in children with chronic hepatitis B (2007) (17)
- Uncover the immune biomarkers underlying hepatitis B e antigen (HBeAg) seroconversion: a need for more translational study. (2012) (17)
- Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China. (2015) (17)
- Activated plasmacytoid dendritic cells act synergistically with hepatitis B core antigen-pulsed monocyte-derived dendritic cells in the induction of hepatitis B virus-specific CD8 T-cell response. (2008) (16)
- Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study (2020) (16)
- Primary biliary cholangitis in China (2016) (16)
- Interleukin‐21 mediates hepatitis B virus‐associated liver cirrhosis by activating hepatic stellate cells (2014) (14)
- Effect of combination treatment based on interferon and nucleos(t)ide analogues on functional cure of chronic hepatitis B: a systematic review and meta-analysis (2020) (14)
- Reversal of the CD8+ T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways (2021) (14)
- Upregulation of OX40 ligand on monocytes contributes to early virological control in patients with chronic hepatitis C (2013) (14)
- Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients (2022) (14)
- Response to interferon-alpha treatment correlates with recovery of blood plasmacytoid dendritic cells in children with chronic hepatitis B. (2007) (13)
- Expression of CD39 Is Correlated With HIV DNA Levels in Naïve Tregs in Chronically Infected ART Naïve Patients (2019) (13)
- Skewed CD39/CD73/adenosine pathway contributes to B-cell hyperactivation and disease progression in patients with chronic hepatitis B (2020) (12)
- Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19 (2021) (12)
- Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial (2021) (11)
- The efficacy of miRNA122, a novel therapeutic target, for predicting the progression of hepatocellular carcinoma (HCC) (2011) (10)
- Risk factors for liver-related mortality in chronic hepatitis C patients: a deceased case-living control study. (2014) (9)
- Monkeypox outbreak: A novel threat after COVID-19? (2022) (9)
- Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 8th Edition): Interpretation of Updated Key Points (2021) (9)
- Dynamics of HIV reservoir decay and naïve CD4 T-cell recovery between immune non-responders and complete responders on long-term antiretroviral treatment. (2021) (9)
- Transient Liver Injury Associated With the Early Recovery of HCV-Specific T-Cell Responses and HCV Rebound in HIV-1/HCV Coinfected Patients Undergoing Highly Active Antiretroviral Therapy (2013) (9)
- High population-attributable fractions of traditional risk factors for non-AIDS-defining diseases among people living with HIV in China: a cohort study (2021) (9)
- Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19 (2021) (9)
- HIV Reservoir Decay and CD4 Recovery Associated With High CD8 Counts in Immune Restored Patients on Long-Term ART (2020) (9)
- 3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China (2021) (8)
- Skewed CD39/CD73/adenosine pathway in B cells is associated with innate immune hyperactivation in chronic HIV-1 infection (2019) (8)
- Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19? (2020) (8)
- Characteristics of Vδ1(+) and Vδ2(+) γδ T cell subsets in acute liver allograft rejection. (2013) (8)
- Mechanism of C5a-induced immunologic derangement in sepsis (2017) (8)
- Erratum: Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis (Cell Metabolism (2018) 27(2) (339–350.e3)(S1550413118300561)(10.1016/j.cmet.2018.01.007)) (2018) (7)
- [BTLA Characterization and its association with disease progression in patients with chronic HIV-1 infection.]. (2009) (7)
- 1 PD-1 upregulation is correlated with HIV-specific memory CD8 + T-cell exhaustion in typical progressors, but not in long-term non-progressors (2007) (7)
- A pilot study on the characteristics of circulating T follicular helper cells in liver transplant recipients. (2018) (7)
- Immune Dysfunctions of CD56neg NK Cells Are Associated With HIV-1 Disease Progression (2022) (6)
- HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells (2016) (6)
- Human umbilical cord mesenchymal stem cell transfusion in immune non-responders with AIDS: a multicenter randomized controlled trial (2021) (6)
- Global transcriptomic characterization of T cells in individuals with chronic HIV-1 infection (2022) (6)
- Single-cell landscape of immunological responses in COVID-19 patients (2020) (6)
- A survey of knowledge about hepatitis B among new military recruits in China (2017) (5)
- Outbreak of Mycoplasma pneumoniae at a military academy (2020) (5)
- Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity (2021) (5)
- Efficacy and safety of elbasvir/grazoprevir in treatment‐naive Chinese adults with hepatitis C virus infection: A randomized trial (2020) (5)
- Hepatitis C: milestones from discovery to clinical cure (2020) (5)
- Epidemiological trends of severely immunosuppressed people living with HIV at time of starting antiretroviral treatment in China during 2005-2018. (2021) (5)
- Changes of Damage Associated Molecular Patterns in COVID-19 Patients (2021) (5)
- Tamibarotene: a new hope for therapeutic efficacy in hepatocellular carcinoma patients (2013) (5)
- Characteristics of HIV‐1‐specific CD8 T‐cell responses and their role in loss of viremia in children chronically infected with HIV‐1 undergoing highly active antiretroviral therapy (2006) (5)
- [Expression of B7-H1 on peripheral myeloid dendritic cells in patients with HIV infection and its correlation with diseases progression]. (2010) (5)
- Host-directed therapies for COVID-19 (2021) (5)
- Activated γδ T cells exhibit cytotoxicity and the capacity for viral clearance in patients with acute hepatitis B. (2019) (5)
- Progressive CD 127 down-regulation correlates with increased apoptosis of CD 8 T cells during chronic HIV-1 infection (2009) (5)
- Diagnosis and Treatment Guidelines for Mesenchymal Stem Cell Therapy for Coronavirus Disease 2019 (Beijing, 2021) (2021) (4)
- [Characteristics of peripheral NK cells in hepatocellular carcinoma patients]. (2010) (4)
- Activation-induced pyroptosis contributes to the loss of MAIT cells in chronic HIV-1 infected patients (2022) (4)
- Higher Death Rates in the Italian COVID-19 Outbreak: A Comparative Modelling Analysis of 8,342 Italy and 44,672 China Cases (2020) (4)
- An immunopathogenic perspective of interleukin-1 signaling (2020) (4)
- Implications of the accumulation of CXCR5+ NK cells in lymph nodes of HIV-1 infected patients (2021) (4)
- Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis. (2018) (4)
- Novel synthetic immunostimulators with a thiazolidin-4-one ring promote the cytotoxicity of human NK cells via ERK1/2 activation in vitro. (2013) (4)
- Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer (2022) (4)
- Progress and challenge in the treatment of end-stage liver disease with stem cells (2013) (3)
- Low platelets: a new and simple prognostic marker for patients with hepatitis E virus-related acute liver failure (2022) (3)
- [The phenotype and function of CD4+ CD25+ regulatory T cells in hepatitis B patients]. (2006) (3)
- Increased Neutrophil Aging Contributes to T Cell Immune Suppression by PD-L1 and Arginase-1 in HIV-1 Treatment Naïve Patients (2021) (3)
- Long‐term benefits of interferon‐α therapy in children with HBeAg‐positive immune‐active chronic hepatitis B (2021) (3)
- High levels of circulating GM-CSF+CD4+ T cells are predictive of poor outcomes in sepsis patients: a prospective cohort study (2018) (3)
- Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC (2021) (3)
- Chinese expert consensus on coronavirus disease 2019 vaccination for breast cancer patients (2021) (3)
- OL-041 Apoptosis of CD8+ T-cells in HIV-1-infected typical progressors, but not in long-term non-progressors (2008) (3)
- Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy (2022) (3)
- Analysis of cause of death in patients with liver diseases: report of 1890 cases (2014) (3)
- Systematic Discovery and Pathway Analyses of Metabolic Disturbance in COVID-19 (2021) (3)
- Compromised long‐lived memory CD8+ T cells are associated with reduced IL‐7 responsiveness in HIV‐infected immunological nonresponders (2021) (2)
- Increased IL-22-producing cells contribute to liver fibrosis through promoting Th17 migration in chronic HBV patients (P3363) (2013) (2)
- Management of chronic hepatitis B e antigen-negative disease: another step forward. (2012) (2)
- Reply: To PMID 19399912. (2015) (2)
- HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patients (2021) (2)
- Transforming growth factor‐β promotes the function of HIV‐specific CXCR5+CD8 T cells (2020) (2)
- Increased Platelet-CD4+ T Cell Aggregates Are Correlated With HIV-1 Permissiveness and CD4+ T Cell Loss (2021) (2)
- Remission of HIV-related naïve and high-risk Burkitt’s lymphoma treated by autologous stem cell transplantation plus cART (2018) (1)
- [CD160 characterization and its association with disease progression in patients with chronic HIV-1 infection]. (2014) (1)
- HIV-1-Specific CD11c+ CD8+ T Cells Display Low PD-1 Expression and Strong Anti-HIV-1 Activity (2021) (1)
- [Dynamic expression of PD-1 in HBV-specific cytotoxic T lymphocytes correlates with memory T-cell development in acute hepatitis B patients]. (2008) (1)
- Detection of HIV coreceptor CCR5 mutation in uigur population from sinkiang uigur autonomous region (2001) (1)
- Immunopathogenesis of Th17 cells in patients with HBV-associated liver cirrhosis (2013) (1)
- [Immunologically-competent cells in liver infiltrating lymphocytes in patients with chronic severe hepatitis B]. (2007) (1)
- Myeloid derived suppressor cells link HCV persistence with liver inflammation and antiviral efficacy (2013) (1)
- Early bilirubin response in acute-on-chronic hepatitis B liver failure patients treated with corticosteroids predicates a lower 3-month mortality (2016) (1)
- [Clinical profiles of circulating dendritic cell subsets in chronically HBV-infected patients with interferon-alpha treatment]. (2005) (1)
- [Decrease in γδV 2T cells correlates with severity of liver injury and fibrosis in patients with chronic hepatitis B]. (2015) (1)
- Characteristics of Tfh cells in the peripheral blood in recipients of liver allograft: A pilot study (2014) (1)
- [Bringing the antiviral therapy home for chronic hepatitis B patients: host immunity influences the efficacy and disease prognosis]. (2009) (1)
- [PD-1 up-regulation influenced apoptosis of HBV-specific CD8 T cells in patients with acute resolved hepatitis B]. (2009) (1)
- CD4+CD19+ conjugates favor HIV-1 infection and latency during chronic HIV-1 infection. (2020) (1)
- Increased myeloid-derived suppressor cells correlate with viral persistence in patients with chronic hepatitis C (2014) (0)
- Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy in COVID-19 Patients: A Phase 1 Clinical Trial (2020) (0)
- The prediction of immunological dysfunction during antiviral therapy for HCV after liver transplantation: can we improve outcomes? (2013) (0)
- Highly Active Antiretroviral Therapy HIV-1-Infected Children after Treatment Plasmacytoid Dendritic Cells in Differential Restoration of Myeloid and (2006) (0)
- Characteristic changes and their significance of peripheral follicular helper T cell subsets in liver transplant patient (2016) (0)
- Sequencing and Cloning of S Gene of SARS Coronavirus First Found in Beijing Area (2003) (0)
- Reply (2015) (0)
- Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection (2022) (0)
- Reply: HEPATOLOGY, Vol. XX, No. X, 2015 (2016) (0)
- Reply: To PMID 25164003. (2015) (0)
- Correlation of the TCR Diversity Indexes in the Peripheral Blood with Disease Susceptibility and Deterioration in COVID-19 Patients (2022) (0)
- Surveillance for respiratory infectious diseases caused by 6 common viruses in a recruit training site in the Northern region of China (2017) (0)
- [Similarities and differences in definition and clinical diagnosis of acute-on-chronic liver failure: East vs. West]. (2014) (0)
- Su1058 Low Dose Digoxin Protects From NASH and Alcoholic Hepatitis in Mice by Inhibiting Inflammasome Activity and Mitochondrial ROS Production (2015) (0)
- Reply (2015) (0)
- In vivo consequences of liver-specific interleukin-22 expression: implications for human liver disease progression (117.7) (2011) (0)
- The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019 (2021) (0)
- PP-044 Study on characteristics of Th17 in HBV-associated acute on chronic liver failure patients and the correlation with prognosis (2009) (0)
- PP-151 New treatment of cutaneous herpes zoster and control of neurolgia by plumeria alba extract (2009) (0)
- Reply (2016) (0)
- Program (2013) (0)
- Preface (2013) (0)
- [Prospects in researches and applications of liver stem cells]. (2003) (0)
- Boosting host immune immunity for control of viral persistence in chronic hepatitis B:Lighting the way forward (2012) (0)
- [Current progress in immunopathogenesis and immune modulation for autoimmune hepatitis]. (2010) (0)
- Randomised controlled trial: effect of metformin add-on therapy on functional cure in entecavir-treated patients with chronic hepatitis B. (2022) (0)
- Construction and expression of a recombinant expresson vector for IFN-alpha 2b/HBV Pre S2 fusion gene (2000) (0)
- response in chronic hepatitis B patients (2013) (0)
- [Identification of new mutant sites and 894C deletion variant genotyping of HIV-1 coreceptor CCR5 in indigenous Chinese populations]. (2002) (0)
- [Changes of peripheral plasmacytoid dendritic cells and lymphocyte subsets in chronic hepatitis B patients treated with consensus interferon alpha]. (2007) (0)
- [Serial analyses of viral levels and immunocytes during in vitro incubation of peripheral blood mononuclear cells from HIV-infected individuals]. (2005) (0)
- [Anti-viral therapy and immune responses in livers of chronic hepatitis B patients]. (2008) (0)
- Changes of P-selectin and D-dimer in acute patients with deep venous thrombosis (2008) (0)
- [Difference in the CD4+T lymphocytes activation between long term non-progressors and typical progressors of HIV-1 infected patients]. (2007) (0)
- SARS-CoV-2 vaccination in chronic liver disease: a systematic review and meta-analysis (2022) (0)
- Reinfection and Breakthrough Infection of SARS-CoV-2 (2021) (0)
- Effects ofin vivo gene transduction of anti-MDR1 ribozyme in combination with chemotherapy on multidrug-resistant human lymphoma growth in mice (2003) (0)
- Study on isolation and identification of mesenchymal stem cells from human umbilical cord and its hepatic differentiation (2010) (0)
This paper list is powered by the following services: